PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-29
Market cap
$149.38B
P/E ratio
19.31
P/S ratio
2.39x
EPS (TTM)
$1.36
Dividend yield
6.50%
52W range
$21 – $29
Volume
37.7M
WallStSmart proprietary scores
49
out of 100
Grade: C
Sell
Investment rating
2.0
Growth
F4.8
Quality
C6.5
Profitability
B5.3
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$29.00
+8.61%
12-Month target
$26.90
+0.75%
Intrinsic (DCF)
$37.19
Margin of safety
+28.21%
2 Strong Buy8 Buy15 Hold1 Sell2 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $4.50B — positive
+ 28.21% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Revenue declining -1.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $100.33B | $59.55B | $63.63B | $62.58B | $62.58B | $61.8B |
| Net income | $31.36B | $2.13B | $8.02B | $7.77B | $-1.65B | — |
| EPS | — | — | — | — | $1.36 | $2.99 |
| Free cash flow | $26.03B | $4.79B | $9.84B | $9.08B | $4.50B | — |
| Profit margin | 31.26% | 3.58% | 12.60% | 12.42% | 12.40% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | BOURLA, ALBERT | Buy | 22 | $27.19 |
| 2026-04-14 | BOURLA, ALBERT | Buy | 911 | $27.11 |
| 2026-03-31 | BOURLA, ALBERT | Buy | 21 | $28.08 |
Peer comparison
Smart narrative
Pfizer Inc trades at $26.70. representing a P/E of 19.31x trailing earnings. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $62.58B. with profit margins at 12.40%. Our DCF model estimates intrinsic value at $37.19.
Frequently asked questions
What is Pfizer Inc's stock price?
Pfizer Inc (PFE) trades at $26.70.
Is Pfizer Inc overvalued?
Smart Value Score 49/100 (Grade C, Sell). DCF value $37.19.
What is the price target of Pfizer Inc (PFE)?
The analyst target price is $29.00, representing +8.6% upside from the current price of $26.70.
What is the intrinsic value of Pfizer Inc (PFE)?
Based on our DCF model, intrinsic value is $37.19, a +28.2% margin of safety versus $26.70.
What is the future stock price of PFE by 2030?
Our research-backed model estimates Pfizer Inc could reach $135.94 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Pfizer Inc's revenue?
TTM revenue is $62.58B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.39x
ROE8.89%
Beta0.39
50D MA$27.15
200D MA$25.67
Shares out5.69B
Float5.68B
Short ratio—
Avg volume37.7M
Performance
1 week-2.74%
1 month-8.02%
3 months-0.68%
YTD+7.23%
1 year—
3 years—
5 years—